SPX4,080.11+122.48 3.09%
DIA346.15+7.67 2.27%
IXIC11,468.00+484.22 4.41%

CureVac Q3 Sales €11.20M Down From €29.30M YoY. Pretax Loss Of €47.7M. Cash & Cash Equivalents Of €540.9M

Benzinga · 11/16/2022 07:09

CureVac (NASDAQ:CVAC) reported €11.20 million in sales this quarter. This is a 61.77 percent decrease over sales of €29.30 million in the same period last year.